nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorthalidone—CA7—colon cancer	0.823	1	CbGaD
Chlorthalidone—CA5A—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0184	0.166	CbGpPWpGaD
Chlorthalidone—CA5B—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0172	0.155	CbGpPWpGaD
Chlorthalidone—CA12—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0159	0.144	CbGpPWpGaD
Chlorthalidone—CA4—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0127	0.115	CbGpPWpGaD
Chlorthalidone—CA2—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0122	0.11	CbGpPWpGaD
Chlorthalidone—CA1—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0117	0.105	CbGpPWpGaD
Chlorthalidone—CA9—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0103	0.0926	CbGpPWpGaD
Chlorthalidone—CA9—gall bladder—colon cancer	0.00306	0.109	CbGeAlD
Chlorthalidone—Metolazone—CA7—colon cancer	0.00295	0.527	CrCbGaD
Chlorthalidone—Indapamide—CA7—colon cancer	0.00264	0.473	CrCbGaD
Chlorthalidone—CA7—renal system—colon cancer	0.00167	0.0595	CbGeAlD
Chlorthalidone—SLC12A3—renal system—colon cancer	0.00164	0.0583	CbGeAlD
Chlorthalidone—CA5A—liver—colon cancer	0.00153	0.0546	CbGeAlD
Chlorthalidone—CA7—digestive system—colon cancer	0.00137	0.0488	CbGeAlD
Chlorthalidone—SLC12A1—epithelium—colon cancer	0.00135	0.0479	CbGeAlD
Chlorthalidone—SLC12A1—renal system—colon cancer	0.00125	0.0445	CbGeAlD
Chlorthalidone—CA9—digestive system—colon cancer	0.0012	0.0428	CbGeAlD
Chlorthalidone—CA2—gall bladder—colon cancer	0.00116	0.0413	CbGeAlD
Chlorthalidone—CA12—renal system—colon cancer	0.00109	0.0386	CbGeAlD
Chlorthalidone—Hypomagnesaemia—Irinotecan—colon cancer	0.00105	0.0327	CcSEcCtD
Chlorthalidone—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—colon cancer	0.000942	0.00849	CbGpPWpGaD
Chlorthalidone—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—colon cancer	0.000892	0.00804	CbGpPWpGaD
Chlorthalidone—CA12—digestive system—colon cancer	0.00089	0.0317	CbGeAlD
Chlorthalidone—CA1—renal system—colon cancer	0.00086	0.0306	CbGeAlD
Chlorthalidone—Hyperuricaemia—Vincristine—colon cancer	0.000739	0.023	CcSEcCtD
Chlorthalidone—CA2—embryo—colon cancer	0.000736	0.0262	CbGeAlD
Chlorthalidone—CA1—lymphoid tissue—colon cancer	0.000714	0.0254	CbGeAlD
Chlorthalidone—CA1—digestive system—colon cancer	0.000705	0.0251	CbGeAlD
Chlorthalidone—CA5B—vagina—colon cancer	0.000705	0.0251	CbGeAlD
Chlorthalidone—Hypomagnesaemia—Capecitabine—colon cancer	0.000703	0.0219	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Vincristine—colon cancer	0.000698	0.0217	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000673	0.00607	CbGpPWpGaD
Chlorthalidone—CA4—renal system—colon cancer	0.000672	0.0239	CbGeAlD
Chlorthalidone—Appetite absent—Methotrexate—colon cancer	0.000669	0.0208	CcSEcCtD
Chlorthalidone—CA1—bone marrow—colon cancer	0.00065	0.0231	CbGeAlD
Chlorthalidone—Hypercalcaemia—Capecitabine—colon cancer	0.000643	0.02	CcSEcCtD
Chlorthalidone—CA2—epithelium—colon cancer	0.000601	0.0214	CbGeAlD
Chlorthalidone—CA2—smooth muscle tissue—colon cancer	0.000579	0.0206	CbGeAlD
Chlorthalidone—CA2—renal system—colon cancer	0.000557	0.0198	CbGeAlD
Chlorthalidone—CA4—digestive system—colon cancer	0.000551	0.0196	CbGeAlD
Chlorthalidone—Photosensitivity—Fluorouracil—colon cancer	0.000529	0.0165	CcSEcCtD
Chlorthalidone—CA1—liver—colon cancer	0.000525	0.0187	CbGeAlD
Chlorthalidone—CA4—bone marrow—colon cancer	0.000508	0.0181	CbGeAlD
Chlorthalidone—Hyponatraemia—Vincristine—colon cancer	0.0005	0.0155	CcSEcCtD
Chlorthalidone—Hyponatraemia—Irinotecan—colon cancer	0.000487	0.0151	CcSEcCtD
Chlorthalidone—CA2—lymphoid tissue—colon cancer	0.000463	0.0165	CbGeAlD
Chlorthalidone—CA2—digestive system—colon cancer	0.000457	0.0163	CbGeAlD
Chlorthalidone—CA5B—lymph node—colon cancer	0.000456	0.0162	CbGeAlD
Chlorthalidone—Orthostatic hypotension—Irinotecan—colon cancer	0.000443	0.0138	CcSEcCtD
Chlorthalidone—Hypokalaemia—Irinotecan—colon cancer	0.000441	0.0137	CcSEcCtD
Chlorthalidone—Cramp muscle—Irinotecan—colon cancer	0.000436	0.0136	CcSEcCtD
Chlorthalidone—CA2—bone marrow—colon cancer	0.000421	0.015	CbGeAlD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.00042	0.00379	CbGpPWpGaD
Chlorthalidone—CA9—Cellular response to hypoxia—EP300—colon cancer	0.000416	0.00375	CbGpPWpGaD
Chlorthalidone—Pancreatitis—Irinotecan—colon cancer	0.000411	0.0128	CcSEcCtD
Chlorthalidone—CA2—vagina—colon cancer	0.000404	0.0144	CbGeAlD
Chlorthalidone—CA1—lymph node—colon cancer	0.000403	0.0143	CbGeAlD
Chlorthalidone—Eosinophilia—Fluorouracil—colon cancer	0.000397	0.0124	CcSEcCtD
Chlorthalidone—Erectile dysfunction—Vincristine—colon cancer	0.000396	0.0123	CcSEcCtD
Chlorthalidone—CA9—Cellular response to hypoxia—VEGFA—colon cancer	0.000394	0.00355	CbGpPWpGaD
Chlorthalidone—Photosensitivity reaction—Vincristine—colon cancer	0.000393	0.0122	CcSEcCtD
Chlorthalidone—CA5A—Metabolism—CA7—colon cancer	0.000374	0.00338	CbGpPWpGaD
Chlorthalidone—Diabetes mellitus—Capecitabine—colon cancer	0.000373	0.0116	CcSEcCtD
Chlorthalidone—Photosensitivity—Capecitabine—colon cancer	0.000369	0.0115	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Fluorouracil—colon cancer	0.000366	0.0114	CcSEcCtD
Chlorthalidone—Jaundice—Irinotecan—colon cancer	0.000364	0.0113	CcSEcCtD
Chlorthalidone—Vascular purpura—Capecitabine—colon cancer	0.000363	0.0113	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Methotrexate—colon cancer	0.000359	0.0112	CcSEcCtD
Chlorthalidone—CA5B—Metabolism—CA7—colon cancer	0.000349	0.00315	CbGpPWpGaD
Chlorthalidone—Vasculitis—Methotrexate—colon cancer	0.000341	0.0106	CcSEcCtD
Chlorthalidone—CA2—liver—colon cancer	0.00034	0.0121	CbGeAlD
Chlorthalidone—Blood uric acid increased—Methotrexate—colon cancer	0.000339	0.0105	CcSEcCtD
Chlorthalidone—Purpura—Capecitabine—colon cancer	0.000337	0.0105	CcSEcCtD
Chlorthalidone—Agranulocytosis—Fluorouracil—colon cancer	0.000334	0.0104	CcSEcCtD
Chlorthalidone—Hyponatraemia—Capecitabine—colon cancer	0.000326	0.0101	CcSEcCtD
Chlorthalidone—CA12—Metabolism—CA7—colon cancer	0.000324	0.00292	CbGpPWpGaD
Chlorthalidone—CA4—lymph node—colon cancer	0.000315	0.0112	CbGeAlD
Chlorthalidone—Aplastic anaemia—Methotrexate—colon cancer	0.000312	0.00972	CcSEcCtD
Chlorthalidone—Arrhythmia—Irinotecan—colon cancer	0.000299	0.00932	CcSEcCtD
Chlorthalidone—Abdominal pain upper—Capecitabine—colon cancer	0.000296	0.00922	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Capecitabine—colon cancer	0.000296	0.00922	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Methotrexate—colon cancer	0.000296	0.00921	CcSEcCtD
Chlorthalidone—Hypokalaemia—Capecitabine—colon cancer	0.000295	0.00919	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000292	0.00909	CcSEcCtD
Chlorthalidone—Arrhythmia—Fluorouracil—colon cancer	0.000287	0.00893	CcSEcCtD
Chlorthalidone—Muscle spasms—Irinotecan—colon cancer	0.000281	0.00873	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Methotrexate—colon cancer	0.000278	0.00864	CcSEcCtD
Chlorthalidone—Agitation—Vincristine—colon cancer	0.000275	0.00857	CcSEcCtD
Chlorthalidone—Photosensitivity—Methotrexate—colon cancer	0.000275	0.00856	CcSEcCtD
Chlorthalidone—Vertigo—Vincristine—colon cancer	0.000269	0.00838	CcSEcCtD
Chlorthalidone—Abdominal discomfort—Capecitabine—colon cancer	0.000269	0.00836	CcSEcCtD
Chlorthalidone—Leukopenia—Vincristine—colon cancer	0.000268	0.00835	CcSEcCtD
Chlorthalidone—Vertigo—Irinotecan—colon cancer	0.000262	0.00816	CcSEcCtD
Chlorthalidone—Leukopenia—Irinotecan—colon cancer	0.000261	0.00813	CcSEcCtD
Chlorthalidone—CA2—lymph node—colon cancer	0.000261	0.00929	CbGeAlD
Chlorthalidone—CA4—Metabolism—CA7—colon cancer	0.000258	0.00233	CbGpPWpGaD
Chlorthalidone—Photosensitivity reaction—Capecitabine—colon cancer	0.000256	0.00796	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Capecitabine—colon cancer	0.000253	0.00787	CcSEcCtD
Chlorthalidone—Leukopenia—Fluorouracil—colon cancer	0.00025	0.00779	CcSEcCtD
Chlorthalidone—CA2—Metabolism—CA7—colon cancer	0.000247	0.00223	CbGpPWpGaD
Chlorthalidone—Jaundice—Capecitabine—colon cancer	0.000244	0.00758	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Vincristine—colon cancer	0.000239	0.00745	CcSEcCtD
Chlorthalidone—CA1—Metabolism—CA7—colon cancer	0.000237	0.00214	CbGpPWpGaD
Chlorthalidone—Agranulocytosis—Capecitabine—colon cancer	0.000233	0.00726	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Irinotecan—colon cancer	0.000233	0.00726	CcSEcCtD
Chlorthalidone—Anorexia—Vincristine—colon cancer	0.000233	0.00726	CcSEcCtD
Chlorthalidone—Anorexia—Irinotecan—colon cancer	0.000227	0.00707	CcSEcCtD
Chlorthalidone—CA5A—Metabolism—ODC1—colon cancer	0.000227	0.00204	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—CHST5—colon cancer	0.000227	0.00204	CbGpPWpGaD
Chlorthalidone—Thrombocytopenia—Fluorouracil—colon cancer	0.000223	0.00695	CcSEcCtD
Chlorthalidone—Paraesthesia—Vincristine—colon cancer	0.00022	0.00683	CcSEcCtD
Chlorthalidone—Anorexia—Fluorouracil—colon cancer	0.000217	0.00677	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000217	0.00677	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—PTGS2—colon cancer	0.000216	0.00195	CbGpPWpGaD
Chlorthalidone—Paraesthesia—Irinotecan—colon cancer	0.000214	0.00666	CcSEcCtD
Chlorthalidone—Decreased appetite—Vincristine—colon cancer	0.000213	0.00662	CcSEcCtD
Chlorthalidone—CA7—Metabolism—ODC1—colon cancer	0.000212	0.00191	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—CHST5—colon cancer	0.000212	0.00191	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—CHST5—colon cancer	0.000212	0.00191	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—ODC1—colon cancer	0.000212	0.00191	CbGpPWpGaD
Chlorthalidone—Constipation—Vincristine—colon cancer	0.000209	0.00651	CcSEcCtD
Chlorthalidone—CA9—Metabolism—CA7—colon cancer	0.000209	0.00188	CbGpPWpGaD
Chlorthalidone—Decreased appetite—Irinotecan—colon cancer	0.000207	0.00644	CcSEcCtD
Chlorthalidone—Eosinophilia—Methotrexate—colon cancer	0.000207	0.00643	CcSEcCtD
Chlorthalidone—Paraesthesia—Fluorouracil—colon cancer	0.000205	0.00637	CcSEcCtD
Chlorthalidone—Pancreatitis—Methotrexate—colon cancer	0.000205	0.00637	CcSEcCtD
Chlorthalidone—Constipation—Irinotecan—colon cancer	0.000204	0.00634	CcSEcCtD
Chlorthalidone—Arrhythmia—Capecitabine—colon cancer	0.0002	0.00624	CcSEcCtD
Chlorthalidone—Abdominal discomfort—Methotrexate—colon cancer	0.0002	0.00623	CcSEcCtD
Chlorthalidone—Decreased appetite—Fluorouracil—colon cancer	0.000198	0.00617	CcSEcCtD
Chlorthalidone—CA12—Metabolism—CHST5—colon cancer	0.000196	0.00177	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—ODC1—colon cancer	0.000196	0.00177	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—CCND1—colon cancer	0.000195	0.00176	CbGpPWpGaD
Chlorthalidone—Abdominal pain—Vincristine—colon cancer	0.000193	0.00602	CcSEcCtD
Chlorthalidone—Erectile dysfunction—Methotrexate—colon cancer	0.000192	0.00598	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—EP300—colon cancer	0.000191	0.00172	CbGpPWpGaD
Chlorthalidone—Photosensitivity reaction—Methotrexate—colon cancer	0.00019	0.00593	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—CDKN1A—colon cancer	0.000189	0.0017	CbGpPWpGaD
Chlorthalidone—Abdominal pain—Irinotecan—colon cancer	0.000188	0.00586	CcSEcCtD
Chlorthalidone—Muscle spasms—Capecitabine—colon cancer	0.000188	0.00584	CcSEcCtD
Chlorthalidone—Urticaria—Fluorouracil—colon cancer	0.000181	0.00564	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.000181	0.00163	CbGpPWpGaD
Chlorthalidone—Hypersensitivity—Vincristine—colon cancer	0.00018	0.00561	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—EP300—colon cancer	0.000179	0.00162	CbGpPWpGaD
Chlorthalidone—Vertigo—Capecitabine—colon cancer	0.000175	0.00546	CcSEcCtD
Chlorthalidone—Hypersensitivity—Irinotecan—colon cancer	0.000175	0.00546	CcSEcCtD
Chlorthalidone—Asthenia—Vincristine—colon cancer	0.000175	0.00546	CcSEcCtD
Chlorthalidone—Leukopenia—Capecitabine—colon cancer	0.000175	0.00544	CcSEcCtD
Chlorthalidone—Agranulocytosis—Methotrexate—colon cancer	0.000174	0.0054	CcSEcCtD
Chlorthalidone—Asthenia—Irinotecan—colon cancer	0.000171	0.00532	CcSEcCtD
Chlorthalidone—Hypersensitivity—Fluorouracil—colon cancer	0.000168	0.00523	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—NRAS—colon cancer	0.000168	0.00151	CbGpPWpGaD
Chlorthalidone—Diarrhoea—Vincristine—colon cancer	0.000167	0.00521	CcSEcCtD
Chlorthalidone—Diarrhoea—Irinotecan—colon cancer	0.000163	0.00507	CcSEcCtD
Chlorthalidone—Dizziness—Vincristine—colon cancer	0.000162	0.00503	CcSEcCtD
Chlorthalidone—Dizziness—Irinotecan—colon cancer	0.000158	0.0049	CcSEcCtD
Chlorthalidone—CA4—Metabolism—ODC1—colon cancer	0.000156	0.00141	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—CHST5—colon cancer	0.000156	0.00141	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—MYC—colon cancer	0.000156	0.00141	CbGpPWpGaD
Chlorthalidone—Diarrhoea—Fluorouracil—colon cancer	0.000156	0.00486	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Capecitabine—colon cancer	0.000156	0.00486	CcSEcCtD
Chlorthalidone—Vomiting—Vincristine—colon cancer	0.000156	0.00484	CcSEcCtD
Chlorthalidone—Rash—Vincristine—colon cancer	0.000154	0.0048	CcSEcCtD
Chlorthalidone—Dermatitis—Vincristine—colon cancer	0.000154	0.00479	CcSEcCtD
Chlorthalidone—Headache—Vincristine—colon cancer	0.000153	0.00477	CcSEcCtD
Chlorthalidone—Anorexia—Capecitabine—colon cancer	0.000152	0.00473	CcSEcCtD
Chlorthalidone—Vomiting—Irinotecan—colon cancer	0.000151	0.00471	CcSEcCtD
Chlorthalidone—Dizziness—Fluorouracil—colon cancer	0.000151	0.00469	CcSEcCtD
Chlorthalidone—Rash—Irinotecan—colon cancer	0.00015	0.00467	CcSEcCtD
Chlorthalidone—Dermatitis—Irinotecan—colon cancer	0.00015	0.00467	CcSEcCtD
Chlorthalidone—CA2—Metabolism—ODC1—colon cancer	0.00015	0.00135	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—CHST5—colon cancer	0.00015	0.00135	CbGpPWpGaD
Chlorthalidone—Headache—Irinotecan—colon cancer	0.000149	0.00464	CcSEcCtD
Chlorthalidone—Nausea—Vincristine—colon cancer	0.000145	0.00452	CcSEcCtD
Chlorthalidone—Vomiting—Fluorouracil—colon cancer	0.000145	0.00451	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—KRAS—colon cancer	0.000144	0.0013	CbGpPWpGaD
Chlorthalidone—Rash—Fluorouracil—colon cancer	0.000144	0.00448	CcSEcCtD
Chlorthalidone—CA1—Metabolism—ODC1—colon cancer	0.000144	0.0013	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—CHST5—colon cancer	0.000144	0.0013	CbGpPWpGaD
Chlorthalidone—Dermatitis—Fluorouracil—colon cancer	0.000144	0.00447	CcSEcCtD
Chlorthalidone—Paraesthesia—Capecitabine—colon cancer	0.000143	0.00445	CcSEcCtD
Chlorthalidone—Headache—Fluorouracil—colon cancer	0.000143	0.00445	CcSEcCtD
Chlorthalidone—Nausea—Irinotecan—colon cancer	0.000141	0.0044	CcSEcCtD
Chlorthalidone—Decreased appetite—Capecitabine—colon cancer	0.000139	0.00431	CcSEcCtD
Chlorthalidone—Constipation—Capecitabine—colon cancer	0.000136	0.00424	CcSEcCtD
Chlorthalidone—Nausea—Fluorouracil—colon cancer	0.000136	0.00422	CcSEcCtD
Chlorthalidone—Vertigo—Methotrexate—colon cancer	0.000131	0.00407	CcSEcCtD
Chlorthalidone—Leukopenia—Methotrexate—colon cancer	0.00013	0.00405	CcSEcCtD
Chlorthalidone—Urticaria—Capecitabine—colon cancer	0.000127	0.00394	CcSEcCtD
Chlorthalidone—CA9—Metabolism—ODC1—colon cancer	0.000126	0.00114	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—CHST5—colon cancer	0.000126	0.00114	CbGpPWpGaD
Chlorthalidone—Abdominal pain—Capecitabine—colon cancer	0.000126	0.00392	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—HRAS—colon cancer	0.000123	0.00111	CbGpPWpGaD
Chlorthalidone—Hypersensitivity—Capecitabine—colon cancer	0.000117	0.00366	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Methotrexate—colon cancer	0.000116	0.00362	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—AKT1—colon cancer	0.000116	0.00104	CbGpPWpGaD
Chlorthalidone—Asthenia—Capecitabine—colon cancer	0.000114	0.00356	CcSEcCtD
Chlorthalidone—Anorexia—Methotrexate—colon cancer	0.000113	0.00352	CcSEcCtD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000113	0.00102	CbGpPWpGaD
Chlorthalidone—Diarrhoea—Capecitabine—colon cancer	0.000109	0.00339	CcSEcCtD
Chlorthalidone—Paraesthesia—Methotrexate—colon cancer	0.000107	0.00332	CcSEcCtD
Chlorthalidone—Dizziness—Capecitabine—colon cancer	0.000105	0.00328	CcSEcCtD
Chlorthalidone—Decreased appetite—Methotrexate—colon cancer	0.000103	0.00321	CcSEcCtD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000102	0.000922	CbGpPWpGaD
Chlorthalidone—Vomiting—Capecitabine—colon cancer	0.000101	0.00315	CcSEcCtD
Chlorthalidone—Rash—Capecitabine—colon cancer	0.000101	0.00313	CcSEcCtD
Chlorthalidone—Dermatitis—Capecitabine—colon cancer	0.0001	0.00313	CcSEcCtD
Chlorthalidone—Headache—Capecitabine—colon cancer	9.99e-05	0.00311	CcSEcCtD
Chlorthalidone—Nausea—Capecitabine—colon cancer	9.47e-05	0.00295	CcSEcCtD
Chlorthalidone—Urticaria—Methotrexate—colon cancer	9.43e-05	0.00293	CcSEcCtD
Chlorthalidone—Abdominal pain—Methotrexate—colon cancer	9.38e-05	0.00292	CcSEcCtD
Chlorthalidone—Hypersensitivity—Methotrexate—colon cancer	8.74e-05	0.00272	CcSEcCtD
Chlorthalidone—Asthenia—Methotrexate—colon cancer	8.51e-05	0.00265	CcSEcCtD
Chlorthalidone—Diarrhoea—Methotrexate—colon cancer	8.12e-05	0.00253	CcSEcCtD
Chlorthalidone—Dizziness—Methotrexate—colon cancer	7.85e-05	0.00244	CcSEcCtD
Chlorthalidone—Vomiting—Methotrexate—colon cancer	7.55e-05	0.00235	CcSEcCtD
Chlorthalidone—Rash—Methotrexate—colon cancer	7.48e-05	0.00233	CcSEcCtD
Chlorthalidone—Dermatitis—Methotrexate—colon cancer	7.48e-05	0.00233	CcSEcCtD
Chlorthalidone—Headache—Methotrexate—colon cancer	7.43e-05	0.00231	CcSEcCtD
Chlorthalidone—Nausea—Methotrexate—colon cancer	7.05e-05	0.00219	CcSEcCtD
Chlorthalidone—CA9—Cellular responses to stress—CDKN1A—colon cancer	6.63e-05	0.000598	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—EP300—colon cancer	6.31e-05	0.000569	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—ABCB1—colon cancer	5.99e-05	0.00054	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—VEGFA—colon cancer	5.97e-05	0.000539	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—TYMS—colon cancer	5.88e-05	0.000531	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—ABCB1—colon cancer	5.59e-05	0.000505	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—ABCB1—colon cancer	5.59e-05	0.000505	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—TYMS—colon cancer	5.49e-05	0.000495	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—TYMS—colon cancer	5.49e-05	0.000495	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—ABCB1—colon cancer	5.18e-05	0.000467	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—TYMS—colon cancer	5.09e-05	0.000459	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—TP53—colon cancer	4.51e-05	0.000407	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PPARG—colon cancer	4.17e-05	0.000376	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—ABCB1—colon cancer	4.13e-05	0.000373	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—TYMS—colon cancer	4.06e-05	0.000366	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—ABCB1—colon cancer	3.96e-05	0.000357	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PPARG—colon cancer	3.89e-05	0.000351	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PPARG—colon cancer	3.89e-05	0.000351	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—TYMS—colon cancer	3.89e-05	0.000351	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—ABCB1—colon cancer	3.8e-05	0.000343	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—TYMS—colon cancer	3.73e-05	0.000336	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PPARG—colon cancer	3.61e-05	0.000325	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—ABCB1—colon cancer	3.34e-05	0.000301	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—TYMS—colon cancer	3.28e-05	0.000296	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PTGS2—colon cancer	3.28e-05	0.000296	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PTGS2—colon cancer	3.06e-05	0.000276	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PTGS2—colon cancer	3.06e-05	0.000276	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PPARG—colon cancer	2.87e-05	0.000259	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PTGS2—colon cancer	2.84e-05	0.000256	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PPARG—colon cancer	2.76e-05	0.000249	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—EP300—colon cancer	2.73e-05	0.000246	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PPARG—colon cancer	2.64e-05	0.000238	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—EP300—colon cancer	2.55e-05	0.00023	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—EP300—colon cancer	2.55e-05	0.00023	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—EP300—colon cancer	2.36e-05	0.000213	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PPARG—colon cancer	2.32e-05	0.00021	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PTGS2—colon cancer	2.26e-05	0.000204	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PTGS2—colon cancer	2.17e-05	0.000196	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PTGS2—colon cancer	2.08e-05	0.000187	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PIK3CA—colon cancer	2.02e-05	0.000182	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PIK3CA—colon cancer	1.88e-05	0.00017	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PIK3CA—colon cancer	1.88e-05	0.00017	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—EP300—colon cancer	1.88e-05	0.00017	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PTGS2—colon cancer	1.83e-05	0.000165	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—EP300—colon cancer	1.8e-05	0.000163	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PIK3CA—colon cancer	1.74e-05	0.000157	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—EP300—colon cancer	1.73e-05	0.000156	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—AKT1—colon cancer	1.65e-05	0.000149	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—AKT1—colon cancer	1.54e-05	0.000139	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—AKT1—colon cancer	1.54e-05	0.000139	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—EP300—colon cancer	1.52e-05	0.000137	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—AKT1—colon cancer	1.43e-05	0.000129	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PIK3CA—colon cancer	1.39e-05	0.000126	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PIK3CA—colon cancer	1.33e-05	0.00012	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PIK3CA—colon cancer	1.28e-05	0.000115	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—AKT1—colon cancer	1.14e-05	0.000103	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PIK3CA—colon cancer	1.12e-05	0.000101	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—AKT1—colon cancer	1.09e-05	9.83e-05	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—AKT1—colon cancer	1.04e-05	9.42e-05	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—AKT1—colon cancer	9.19e-06	8.28e-05	CbGpPWpGaD
